Gene therapy for inborn errors of immunity: past, present and future

A Fischer - Nature Reviews Immunology, 2023 - nature.com
Inborn errors of immunity (IEI) are diseases caused by genetic mutations that affect the
immune system's ability to fight pathogens, cope with the microbiota or regulate …

[HTML][HTML] Advances in CRISPR/Cas gene therapy for inborn errors of immunity

X Liu, G Li, Y Liu, F Zhou, X Huang, K Li - Frontiers in Immunology, 2023 - frontiersin.org
Inborn errors of immunity (IEIs) are a group of inherited disorders caused by mutations in the
protein-coding genes involved in innate and/or adaptive immunity. Hematopoietic stem cell …

Efficient high-precision homology-directed repair-dependent genome editing by HDRobust

S Riesenberg, P Kanis, D Macak, D Wollny… - Nature …, 2023 - nature.com
Abstract Homology-directed repair (HDR), a method for repair of DNA double-stranded
breaks can be leveraged for the precise introduction of mutations supplied by synthetic DNA …

Development of a versatile nuclease prime editor with upgraded precision

X Li, G Zhang, S Huang, Y Liu, J Tang, M Zhong… - Nature …, 2023 - nature.com
The applicability of nuclease-based form of prime editor (PEn) has been hindered by its
complexed editing outcomes. A chemical inhibitor against DNA-PK, which mediates the …

Impact of CRISPR/HDR editing versus lentiviral transduction on long-term engraftment and clonal dynamics of HSPCs in rhesus macaques

BC Lee, A Gin, C Wu, K Singh, M Grice, R Mortlock… - Cell stem cell, 2024 - cell.com
For precise genome editing via CRISPR/homology-directed repair (HDR), effective and safe
editing of long-term engrafting hematopoietic stem cells (LT-HSCs) is required. The impact …

CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells

J Brault, T Liu, S Liu, A Lawson, U Choi… - Frontiers in …, 2023 - frontiersin.org
Introduction Ex vivo gene therapy for treatment of Inborn errors of Immunity (IEIs) have
demonstrated significant clinical benefit in multiple Phase I/II clinical trials. Current …

Homology-Directed-Repair-Based Genome Editing in HSPCs for the Treatment of Inborn Errors of Immunity and Blood Disorders

D Allen, N Kalter, M Rosenberg, A Hendel - Pharmaceutics, 2023 - mdpi.com
Genome engineering via targeted nucleases, specifically CRISPR-Cas9, has revolutionized
the field of gene therapy research, providing a potential treatment for diseases of the blood …

Gene therapy for inborn error of immunity–current status and future perspectives

A Mudde, C Booth - Current Opinion in Allergy and Clinical …, 2023 - journals.lww.com
As HSC GT is becoming available for more diseases, novel developments should focus on
improving availability while reducing costs of the treatment. Continued follow up of treated …

Malignancy‐associated immune responses: Lessons from human inborn errors of immunity

A Aliyath, A Eni‐Olotu, N Donaldson, P Trivedi - Immunology, 2023 - Wiley Online Library
It is widely understood that cancer is a significant cause of morbidity and mortality
worldwide. Despite numerous available treatments, prognosis for many remains poor, thus …

[HTML][HTML] Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders

V Buffa, JR Alvarez Vargas, A Galy… - Frontiers in Genome …, 2023 - frontiersin.org
Lessons learned from decades-long practice in the transplantation of hematopoietic stem
and progenitor cells (HSPCs) to treat severe inherited disorders or cancer, have set the …